What does low c-peptide mean?

Low C-peptide levels indicate reduced insulin production by the pancreas, which can signal type 1 diabetes, late-stage type 2 diabetes, or pancreatic disorders. Testing C-peptide helps doctors understand your body's natural insulin production and guide appropriate treatment decisions.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding C-Peptide and Its Role in Your Body

C-peptide is a protein that your pancreas releases alongside insulin whenever your body produces this vital hormone. Think of C-peptide as insulin's companion - for every molecule of insulin your pancreas makes, it releases an equal amount of C-peptide into your bloodstream. This one-to-one relationship makes C-peptide an excellent marker for understanding how much insulin your body naturally produces.

Unlike insulin, which your body uses quickly to help cells absorb glucose, C-peptide stays in your bloodstream longer and remains more stable. This stability makes it a more reliable indicator of your pancreatic function than measuring insulin directly. When doctors want to understand whether your pancreas is producing enough insulin, they often turn to C-peptide testing as their go-to diagnostic tool.

What Are Normal C-Peptide Levels?

Normal C-peptide levels typically range from 0.5 to 2.0 nanograms per milliliter (ng/mL) when fasting, though these values can vary slightly between laboratories. After eating, your C-peptide levels naturally rise as your pancreas produces more insulin to handle the incoming glucose from your meal. Understanding where your levels fall within this range helps healthcare providers assess your pancreatic health and insulin production capacity.

C-Peptide Level Interpretation

C-Peptide LevelInterpretationClinical SignificanceTypical Conditions
< 0.5 ng/mL< 0.5 ng/mLLowInsufficient insulin productionType 1 diabetes, late-stage type 2 diabetes, pancreatic damage
0.5-2.0 ng/mL0.5-2.0 ng/mLNormalAdequate insulin productionHealthy individuals, early type 2 diabetes with preserved function
> 2.0 ng/mL> 2.0 ng/mLHighExcess insulin productionInsulin resistance, early type 2 diabetes, insulinoma

C-peptide levels should be interpreted alongside glucose levels and clinical symptoms for accurate diagnosis.

Low C-peptide is generally defined as levels below 0.5 ng/mL during fasting or levels that fail to rise appropriately after eating or during a glucose tolerance test. These low levels suggest that your pancreas isn't producing sufficient insulin, which can have significant implications for your metabolic health and glucose management.

Common Causes of Low C-Peptide

Type 1 Diabetes

Type 1 diabetes is the most common cause of low C-peptide levels. In this autoimmune condition, your immune system mistakenly attacks and destroys the insulin-producing beta cells in your pancreas. As these cells are destroyed, both insulin and C-peptide production plummet. Most people with type 1 diabetes have very low or undetectable C-peptide levels, especially as the disease progresses.

Late-Stage Type 2 Diabetes

While type 2 diabetes typically starts with insulin resistance and high insulin levels, the condition can evolve over time. After years of overworking to produce extra insulin, your pancreatic beta cells can become exhausted and start to fail. This beta cell burnout leads to declining C-peptide levels, indicating that your pancreas can no longer keep up with your body's insulin demands.

Pancreatic Disorders

Various pancreatic conditions can damage the organ's ability to produce insulin and C-peptide. These include chronic pancreatitis, pancreatic cancer, cystic fibrosis-related diabetes, and surgical removal of part or all of the pancreas. Any condition that damages or removes pancreatic tissue can result in reduced C-peptide production.

Understanding your C-peptide levels through regular testing can help identify these conditions early and guide appropriate treatment strategies. Regular monitoring becomes especially important if you have risk factors for diabetes or pancreatic disease.

Symptoms Associated with Low C-Peptide

Low C-peptide levels themselves don't cause symptoms directly. Instead, the symptoms you experience relate to the insufficient insulin production that low C-peptide indicates. When your body can't produce enough insulin, glucose builds up in your bloodstream instead of entering your cells, leading to various metabolic disruptions.

Common symptoms associated with the insulin deficiency that low C-peptide represents include:

  • Frequent urination, especially at night
  • Excessive thirst that doesn't seem to go away
  • Unexplained weight loss despite normal or increased appetite
  • Persistent fatigue and weakness
  • Blurred vision
  • Slow-healing wounds or frequent infections
  • Tingling or numbness in hands and feet

These symptoms often develop gradually in type 2 diabetes but can appear suddenly and severely in type 1 diabetes. If you're experiencing multiple symptoms from this list, it's crucial to seek medical evaluation promptly.

Why C-Peptide Testing Matters

Differentiating Diabetes Types

One of the most valuable uses of C-peptide testing is distinguishing between type 1 and type 2 diabetes. This distinction is crucial because the treatment approaches differ significantly. People with type 1 diabetes typically have very low or absent C-peptide levels and require insulin therapy from diagnosis. Those with type 2 diabetes usually have normal or high C-peptide levels initially, indicating their pancreas is still producing insulin but their body isn't using it effectively.

Monitoring Pancreatic Function

For people with type 2 diabetes, tracking C-peptide levels over time provides valuable insights into disease progression. Declining C-peptide levels may signal that it's time to adjust treatment strategies, potentially adding insulin therapy to maintain optimal glucose control. This proactive monitoring helps prevent complications and ensures you're receiving the most appropriate treatment for your current condition.

Guiding Treatment Decisions

C-peptide levels help healthcare providers make informed decisions about your diabetes management. If your C-peptide is very low, oral medications that work by stimulating insulin production won't be effective since your pancreas has limited capacity to respond. In these cases, insulin therapy becomes necessary to maintain healthy blood glucose levels.

Testing Methods and What to Expect

C-peptide testing is typically done through a simple blood draw, either as a fasting test or as part of a stimulation test where you consume glucose to see how your pancreas responds. The fasting test provides baseline information about your pancreatic function, while stimulation tests offer insights into your pancreas's reserve capacity to produce insulin when challenged.

Some healthcare providers may also order a 24-hour urine C-peptide test, which measures the total amount of C-peptide your body produces over a full day. This test can be particularly useful for getting a comprehensive picture of your pancreatic function without the variations that can occur with single blood draws.

Regular monitoring of C-peptide alongside other metabolic markers provides a comprehensive view of your metabolic health. Advanced testing programs now make it possible to track these important biomarkers from the comfort of your home, allowing for more frequent monitoring and better disease management.

Treatment Approaches for Low C-Peptide

Treatment for low C-peptide focuses on replacing the insulin your body can't produce adequately. The specific approach depends on your remaining pancreatic function, overall health, and individual needs. Your healthcare team will work with you to develop a personalized treatment plan that maintains stable blood glucose levels while fitting your lifestyle.

Insulin Therapy Options

For those with very low C-peptide levels, insulin therapy becomes essential. Modern insulin regimens offer various options, from long-acting basal insulin that provides steady background coverage to rapid-acting insulin for mealtime glucose control. Some people benefit from insulin pumps that deliver continuous insulin throughout the day, closely mimicking natural pancreatic function.

Lifestyle Modifications

While low C-peptide indicates reduced insulin production that lifestyle changes alone can't fix, healthy habits remain crucial for optimal glucose management. A balanced diet focusing on complex carbohydrates, lean proteins, and healthy fats helps minimize glucose spikes. Regular physical activity improves insulin sensitivity, meaning your body can use the limited insulin you produce more effectively. Stress management and adequate sleep also play vital roles in glucose control.

Emerging Therapies

Research continues to explore ways to preserve or restore pancreatic function in people with low C-peptide. These include immunotherapy approaches for type 1 diabetes that aim to halt the autoimmune attack on beta cells, and regenerative medicine strategies attempting to replace lost beta cells. While these treatments remain largely experimental, they offer hope for future management options beyond insulin replacement.

Living Well with Low C-Peptide

A diagnosis of low C-peptide doesn't mean you can't live a full, healthy life. With proper management and regular monitoring, people with low C-peptide levels can maintain excellent glucose control and prevent complications. The key lies in understanding your condition, working closely with your healthcare team, and staying consistent with your treatment plan.

Technology has made managing low C-peptide easier than ever. Continuous glucose monitors provide real-time feedback on your glucose levels, helping you make informed decisions about insulin dosing and lifestyle choices. Smart insulin pens track your doses, and apps help you log meals, exercise, and glucose patterns. These tools empower you to take control of your health despite reduced pancreatic function.

Building a strong support system is equally important. Connecting with others who have similar conditions, whether through in-person support groups or online communities, provides valuable emotional support and practical tips. Diabetes educators, nutritionists, and mental health professionals specializing in chronic conditions can all play important roles in your care team.

The Importance of Regular Monitoring

If you have low C-peptide or risk factors for pancreatic dysfunction, regular monitoring becomes your early warning system. Tracking not just C-peptide but also related markers like glucose, HbA1c, and insulin levels provides a comprehensive picture of your metabolic health. This information helps you and your healthcare provider make timely adjustments to your treatment plan, potentially preventing complications before they develop.

Consider establishing a monitoring schedule that includes quarterly or biannual testing of key metabolic markers. This frequency allows you to track trends over time while catching changes early enough to intervene effectively. Modern at-home testing options make this level of monitoring more accessible and convenient than ever before.

Remember that C-peptide is just one piece of the metabolic health puzzle. Comprehensive testing that includes lipid profiles, inflammatory markers, and other hormones provides the full context needed to optimize your health. By taking a proactive approach to monitoring and management, you can maintain excellent health outcomes despite low C-peptide levels.

References

  1. Jones, A. G., & Hattersley, A. T. (2013). The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabetic Medicine, 30(7), 803-817.[Link][PubMed][DOI]
  2. Leighton, E., Sainsbury, C. A., & Jones, G. C. (2017). A practical review of C-peptide testing in diabetes. Diabetes Therapy, 8(3), 475-487.[Link][PubMed][DOI]
  3. Palmer, J. P., Fleming, G. A., Greenbaum, C. J., et al. (2004). C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function. Diabetes, 53(1), 250-264.[Link][PubMed][DOI]
  4. Saisho, Y. (2016). Postprandial C-peptide to glucose ratio as a marker of β cell function: implication for the management of type 2 diabetes. International Journal of Molecular Sciences, 17(5), 744.[Link][PubMed][DOI]
  5. American Diabetes Association. (2023). Standards of Medical Care in Diabetes—2023. Diabetes Care, 46(Supplement 1), S1-S291.[Link][DOI]
  6. Shields, B. M., McDonald, T. J., Oram, R., et al. (2018). C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase. Diabetes Care, 41(7), 1486-1492.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my C-peptide at home?

You can test your C-peptide at home with SiPhox Health's Heart & Metabolic Program or the Ultimate 360 Health Program. Both programs include C-peptide testing along with other essential metabolic markers, providing comprehensive insights into your pancreatic function and metabolic health.

What is the difference between low C-peptide in type 1 vs type 2 diabetes?

In type 1 diabetes, C-peptide levels are typically very low or undetectable from the onset due to autoimmune destruction of pancreatic beta cells. In type 2 diabetes, C-peptide levels are usually normal or high initially but may decline over years as beta cells become exhausted from overproduction.

Can C-peptide levels improve once they're low?

Generally, very low C-peptide levels indicate permanent beta cell damage that cannot be reversed. However, in early type 2 diabetes or prediabetes, lifestyle interventions may help preserve remaining beta cell function and slow further decline. Some people in the 'honeymoon phase' of type 1 diabetes may temporarily maintain some C-peptide production.

Should I test C-peptide if I don't have diabetes?

Testing C-peptide can be valuable if you have risk factors for diabetes (family history, obesity, PCOS) or symptoms of high blood sugar. It provides early insights into pancreatic function before glucose levels become abnormal, allowing for earlier intervention and potentially preventing or delaying diabetes onset.

How often should I monitor my C-peptide levels?

If you have diabetes or are at risk, testing C-peptide every 3-6 months helps track pancreatic function over time. For those with stable levels and good glucose control, annual testing may be sufficient. Your healthcare provider can recommend the best testing frequency based on your individual situation.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details